Global epidemic BA.5 Total invasion had an impact on the market for polymerase test
A new coronavirus pandemic is spreading rapidly across Asia, prompting countries such as Japan to warn their populations to take precautions to slow the spread and prevent their healthcare systems from being overwhelmed.
In Japan, the number of new coronavirus cases has surged to levels not seen since the beginning of the year, reports say. "The number of new cases is increasing in every prefecture in Japan and appears to be spreading rapidly," health Minister Shigeryuki Goto said.
Tokyo has raised its alert level to the highest. In addition, Japan's National Infectious Disease Research Institute estimated that nearly 80% of the patients infected with the omicron virus subtype BA.5 have been infected. It is expected to completely replace the original subtype in the first week of August.
South Korea was lauded for its early response to the outbreak, but as of Wednesday, the number of new cases in a single da
y in a week had tripled to more than 39,000. Officials and experts expect South Korea to see 200,000 new cases a day between mid-August and the end of September.
Cases are on the decline in Thailand, but infections have increased in Indonesia, reaching their highest level since March. New cases and hospitalizations in the Philippines remain low, but the government has warned that the number of cases could increase at least 20-fold by the end of the month.
Australia has warned that it could be hit hardest by the coronavirus outbreak in the coming weeks, driven by variants of Omicron BA.4 and BA.5. Authorities said they expected "millions" of new cases.
The New Zealand government on Thursday announced free face masks and rapid antigen tests to ease pressure on the country's health system. "There is no doubt that the surge in COVID-19 cases and hospitalizations, the worst flu season in recent memory and the associated staff absenteeism are putting medical staff and the entire healthcare system under enormous strain," COVID-19 Response Minister Aisha Verrol said in a statement.
Buy high quality and effective DNA & RNA
nucleic acid extraction
reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables
or polymerase test
. Send an email to:
and our professional sales engineer will get back to you within 48 hours.
Overview of market area prospect of polymerase test
By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). North America is further divided into countries such as the United States and Canada. The European region is further divided into The United Kingdom, France, Germany, Italy, Spain, Russia and the rest of Europe. The Asia Pacific region is further subdivided into China, Japan, Korea, India, Australia, Southeast Asia and the rest of Asia Pacific. The Latin America region is further subdivided into Brazil, Mexico and the rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa and the rest of MEA.
Analysis and forecast of the market size of PCR diagnostic industry
Polymerase chain reaction (PCR) is a nucleic acid synthesis technology that uses the principle of DNA double-strand replication to replicate specific DNA fragments in vitro. With this technology, the detection equipment can amplify the target gene in a large number in a short time, expanding the target gene fragment to the order of millions to billions, thus achieving high sensitivity detection. At present, polymerase chain reaction (PCR) diagnosis of infectious diseases such as hepatitis, venereal disease, intestinal respiratory disease and tumor single gene detection is an important application field. In 2020, polymerase chain reaction (PCR) diagnostic technology was identified as the "gold standard" for COVID-19 diagnosis due to its high sensitivity and accuracy.
China's PCR diagnostic market is developing rapidly, with the market size growing rapidly from about RMB 2.37 billion in 2015 to about RMB 5.93 billion in 2019, with a compound annual growth rate of 25.8%. China's PCR industry experienced explosive growth due to the huge demand for testing caused by the outbreak of COVID-19 in 2020, and the market size of China's PCR diagnostic industry exceeded 10 billion yuan in 2020. With the introduction of a large number of PCR diagnostic instruments, the PCR diagnostic industry will enter a new stage of development. It is expected that the PCR diagnostic industry will maintain a double-digit growth rate, and the market size of the PCR diagnostic industry will reach about 23.42 billion yuan in 2030 based on the factory price, and the cagR will reach about 13.3% from 2019 to 2030.
Market Demand of
The DNA/RNA Extraction Kit market and other polymerase tests are projected to grow at a CAGR of 8.26% during the forecast period 2022-2027.
The COVID-19 pandemic has impacted the polymerase test market for a short time due to restrictions on different business and research activities for polymerase tests. In addition, diagnostic tests for other diseases and medical conditions in hospitals and other clinical diagnostic facilities have been affected as COVID-19 has led to fewer patients taking tests. However, the high rate of COVID-19 infection and research activities are undertaken by major companies in the field of sequencing to expand their understanding of the virus and its origins, as well as molecular diagnostics of the SARS-COV-2 virus, have led to the development and launch of many DNA - and RNA-BASED COVID-19 kits, The kits proved so important that they were in great demand.
Market drivers for
The growth of the DNA/RNA extraction kit market is primarily driven by increased investment in R&D activities in different areas, including molecular diagnostics for different chronic and infectious diseases. For example, the US spent $842 billion on R&D activities in 2020, followed by China at $664 billion, according to the ORGANISATION for Economic Co-operation and Development. Technological advances worldwide, new product launches by major market players, and an increase in cancer cases are also likely to complement the growth of the markets under study.
Other factors, such as increased demand for automation of DNA/RNA extraction technologies, new user-friendly and easy extraction kits, and DNA/RNA for analysis of new diseases causing microorganisms, are expected to drive DNA/RNA growth. RNA Extraction Kit market during the forecast period. Therefore, low awareness and availability of the kit and low market penetration in less developed and developing regions around the world are the major factors limiting the growth of the DNA/RNA extraction kit market.
North America is expected to dominate the global polymerase test market during the forecast period
North America, which holds a major share in the polymerase test market, is expected to show a similar trend during the forecast period, mainly due to the high level of R&D activity in the region and the presence of major market players in the region constantly developing their products for the markets studied.
In the region, the US is expected to take a major share of the DNA/RNA extraction kit market due to heavy investment in R&D by government and private entities, increased demand for polymerase tests, and the rising prevalence of chronic diseases.
The polymerase test professional supplier manufacturer -Geneture
is a professional supplier of Nucleic Acid Extraction Reagent,Automatic Nucleic Acid Extraction,Lab consumables, Real-time PCR, Covid-19 Rapid Test Supplier.
Buy high quality and effective DNA & RNA nucleic acid extraction reagent, lab consumables, automatic nucleic acid extractions, real-time PCR equipment and consumables.
Feel free to get a qutoe
send an email
and our professional sales engineer will get back to you within 48 hours.